The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma

Purpose To assess the significance of CA-125 regression as a prognostic indicator and predictor of optimal cytoreduction at interval debulking surgery (IDS) in women with ovarian or primary peritoneal carcinoma receiving neoadjuvant chemotherapy (NAC). Methods 63 women treated between 2004 and 2007...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of gynecology and obstetrics 2011-07, Vol.284 (1), p.221-227
Hauptverfasser:	Vasudev, Naveen S., Trigonis, Ioannis, Cairns, David A., Hall, Geoff D., Jackson, David P., Broadhead, Timothy, Buxton, John, Hutson, Richard, Nugent, David, Perren, Timothy J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Agents - therapeutic use CA-125 Antigen - blood Carcinoma - blood Carcinoma - diagnosis Carcinoma - drug therapy Chemotherapy Endocrinology Female Gastric cancer Gynecologic Oncology Gynecology Human Genetics Humans Kaplan-Meier Estimate Medicine Medicine & Public Health Middle Aged Multivariate Analysis Neoadjuvant Therapy Obstetrics/Perinatology/Midwifery Ovarian cancer Ovarian Neoplasms - blood Ovarian Neoplasms - diagnosis Ovarian Neoplasms - drug therapy Peritoneal Neoplasms - blood Peritoneal Neoplasms - diagnosis Peritoneal Neoplasms - drug therapy Predictive Value of Tests Prognosis Remission Induction Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!